Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Rxi Pharmaceuticals (RXII)

0.5699 -0.0001 (-0.0175%)

5/25/2017  3:57pm

Open:

0.5650

Pre. Close:

0.5700

High:

0.5899

Low:

0.5600

Volume:

90,217

Market Cap:

12.61M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.61 - 0.62

0.62 - 0.63

Low:

0.52 - 0.53

0.53 - 0.55

Close:

0.54 - 0.56

0.56 - 0.59

Technical analysis  (as of: 2017-05-25 4:49:43 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 0.75     One year: 0.85

Support:

Support1: 0.51    Support2: 0.42

Resistance:

Resistance1: 0.65    Resistance2: 0.73

Pivot:

0.57

Moving Averages:

MA(5): 0.57     MA(20): 0.58

MA(100): 0.70     MA(250): 1.41

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.04

%K %D:

%K(14,3): 47.50     %D(3): 46.14

RSI:

RSI(14): 42.63

52-Week:

High: 3.2700  Low: 0.5100  Change(%): -73.7

Average Vol(K):

3-Month: 939  10-Days 195

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
RXII has closed below upper band by 44.7%. Bollinger Bands are 64.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to RXII's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 23 May 2017 11:03:45 GMT
RXi Pharmaceuticals to Present at the 3rd Annual Immuno-Oncology BD&L and ...

Mon, 01 May 2017 11:03:23 GMT
RXi Pharmaceuticals Corporation Selected to Present at the Cavendish Global ...

Wed, 21 Dec 2016 14:48:45 GMT
RXi Pharmaceuticals Announces Closing of $11.5 Million Underwritten Public ...

Thu, 20 Apr 2017 11:03:45 GMT
BRIEF-RXI Pharmaceuticals Corp says to present an update on its consumer ...

Tue, 22 Mar 2016 09:33:45 GMT
Worldwide Analysis on Keloid Treatment Market Strategies and Forecasts, 2016 ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

22.00

Shares Float (M)

18.71

% Held by Insiders

% Held by Institutions

Shares Short (K)

1400

Shares Short Prior Month (K)

1370

Stock Financials

EPS

-1.640

EPS Est. Current Year

-1.770

EPS Est. Next Year

-0.570

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

0.560

PEG Ratio

Profit Margin

Operating Margin

-47447.37

Return on Assets (ttm)

-45.9

Return on Equity (ttm)

-91.1

Qtrly Rev. Growth

Gross Profit (p.s.)

0.002

Sales Per Share

0.001

EBITDA (p.s.)

-0.407

Qtrly Earnings Growth

Operating Cash Flow (M)

-7.76

Levered Free Cash Flow (M)

-4.40

FoxReading.com

Valuation

P/E

-0.35

P/E Growth Ratio

P/BV

1.02

P/S

659.92

P/CF

-1.62

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-07-24

Last Split Ratio

0.033

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.